Medicare Enrolled

Dr. James McKinnell, M.D.

Infectious Disease · Torrance, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
1000 W CARSON ST FL 2, Torrance, CA 90502
3102223814
In practice since 2007 (18 years)
NPI: 1942403035 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. McKinnell from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. McKinnell? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. McKinnell

Dr. James McKinnell is an infectious disease specialist in Torrance, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. McKinnell performed 2,070 Medicare services across 693 unique beneficiaries.

Between the years covered by Open Payments, Dr. McKinnell received a total of $524,066 from 26 pharmaceutical and/or device companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. McKinnell is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 18% volume in CA $524,066 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,070
Medicare services
Top 18% in CA for infectious disease
693
Unique beneficiaries
$108
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~115 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
1,590 $99 $210
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
275 $141 $390
Critical care, first 30-74 min
Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient.
121 $172 $455
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
84 $65 $150
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$524,066
Total received (2018-2024)
Avg $74,867/year across 7 years
Top 1% in CA for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
26
Companies
838
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$415,758 (79.3%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$105,881 (20.2%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,427 (0.5%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$91,916
2023
$49,276
2022
$20,536
2021
$8,940
2020
$27,048
2019
$165,270
2018
$161,080

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$50,729
Remel, Inc.
$16,500
AIMMUNE THERAPEUTICS, INC.
$12,240
Melinta Therapeutics, LLC
$11,168
AstraZeneca Pharmaceuticals LP
$1,264
Shionogi Inc
$16
Top 3 companies account for 86.5% of 2024 payments
All-time payments by company (2018-2024) ›
Allergan Inc.
$237,914
Remel, Inc.
$84,480
ABBVIE INC.
$77,112
Allergan, Inc.
$55,971
Melinta Therapeutics, Inc.
$12,601
AIMMUNE THERAPEUTICS, INC.
$12,240
Melinta Therapeutics, LLC
$12,124
Ferring Pharmaceuticals Inc.
$10,866
Paratek Pharmaceuticals, Inc.
$5,386
TETRAPHASE PHARMACEUTICALS, INC.
$4,944
Insmed, Inc.
$3,265
Alexion Pharmaceuticals, Inc.
$1,840
PFIZER INC.
$1,400
AstraZeneca Pharmaceuticals LP
$1,264
Shionogi Inc
$1,201
Accelerate Diagnostics Inc.
$863
bioMerieux
$143
Astellas Pharma US Inc
$92
Genentech, Inc.
$76
Merck Sharp & Dohme LLC
$72
Gilead Sciences, Inc.
$71
Janssen Pharmaceuticals, Inc
$44
Merck Sharp & Dohme Corporation
$32
Mylan Specialty L.P.
$29
La Jolla Pharmaceutical Company
$20
Astellas Pharma Global Development
$16
Top 3 companies account for 76.2% of all-time payments
Associated products mentioned in payments ›
ACCELERATE PHENO · AVYCAZ · Arikayce · CRESEMBA · DALVANCE · DIFICID · Fetroja · INVOKANA · Kimyrsa · NUZYRA · Orbactiv · REBYOTA · Rezzayo · SOLIRIS · TEFLARO · Vabomere · XARELTO · XERAVA · Xerava · Xofluza · Yupelri · ZENPEP · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (79%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in infectious disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for infectious disease in CA.

Looking for an infectious disease specialist in Torrance?
Compare infectious diseases in the Torrance area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
269
Per 100K population
2.7
County median income
$87,760
Nearest hospital
KAISER FOUNDATION HOSPITAL - SOUTH BAY
2.4 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. McKinnell is a mixed practice specialist, with above-average Medicare volume (top 18% in CA), with speaking/promotional industry engagement in the top 1% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. McKinnell experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. McKinnell performed 1,590 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. McKinnell receive payments from pharmaceutical companies?
Yes. Dr. McKinnell received a total of $524,066 from 26 companies across 838 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. McKinnell's costs compare to other infectious diseases in Torrance?
Dr. McKinnell's average Medicare payment per service is $108. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. McKinnell) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →